Chen, Chuen-FeiChuen-FeiChenWEN-CHUNG LEEYang, Hwai-IHwai-IYangChang, Hung-ChuenHung-ChuenChangJen, Chin-LanChin-LanJenIloeje, Uchenna HUchenna HIloejeSu, JunJunSuCHUHSING KATE HSIAOWang, Li-YuLi-YuWangYou, San-LinSan-LinYouLu, Sheng-NanSheng-NanLuChen, Chien-JenChien-JenChen2020-11-192020-11-192011-100016-5085https://scholars.lib.ntu.edu.tw/handle/123456789/521917It is not clear whether risk for hepatocellular carcinoma can be accurately determined from long-term changes in serum levels of hepatitis B virus (HBV) DNA or alanine aminotransferase (ALT).enLiver Disease; Long-term Follow-up Study; Chronic Hepatitis B[SDGs]SDG3alanine aminotransferase; virus DNA; adult; alanine aminotransferase blood level; article; cancer incidence; cancer risk; chronic hepatitis; controlled study; disease association; female; follow up; Hepatitis B virus; human; liver cell carcinoma; major clinical study; male; prediction; priority journal; virus carrier; virus loadChanges in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinomajournal article10.1053/j.gastro.2011.06.03621703214WOS:000295593700031